BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 14/08/2013

FDA Transfers Oversight of Live Cell Wound Care Products to CBER

The FDA is consolidating its oversight of wound care products containing live cells, transferring responsibility from CDRH to CBER, to improve coordination and efficiency in regulatory activities.

Source: Federal Register — Food and Drug AdministrationOpen original release →